From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
Group
\( \overline{x}\pm S \)
t
P
The treatment group
66.87 ± 6.45
−0.781
0.435
The control group
66.55 ± 6.08